Jazz Pharmaceuticals revenue
Jazz Pharmaceuticals (JAZZ) reported revenue of $4.27 B for fiscal year 2025, +4.88% compared with the year before. Over the last 12 months revenue was $4.72 B.
Revenue 2025$4.27 B
Change+4.88%
World rank#862
Market cap$15.18 B
Revenue by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $4.27 B | +4.88% |
| 2024 | $4.07 B | +6.12% |
| 2023 | $3.83 B | +4.78% |
| 2022 | $3.66 B | — |
Data: company filings via Yahoo Finance, updated 2026-11-20. Not investment advice.